Mills Biopharmaceuticals
1992
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
4
FINANCING ROUNDS
Description
Provider of brachytherapy treatment services. The company is engaged in supplying of Iodine 125 and Palladium Pd-103 seeds for low dose prostate brachytherapy treatment.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Primary Office
- 120 NorthEast 26th Street
- Oklahoma City, OK 73105
- United States
Mills Biopharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Mills Biopharmaceuticals‘s full profile, request access.
Request full access to PitchBookMills Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Mills Biopharmaceuticals‘s full profile, request access.
Request full access to PitchBook